Pages that link to "Q39882714"
Jump to navigation
Jump to search
The following pages link to From the Gla domain to a novel small-molecule detector of apoptosis (Q39882714):
Displaying 49 items.
- Imaging radiation response in tumor and normal tissue (Q26798266) (← links)
- Biomarkers and molecular probes for cell death imaging and targeted therapeutics (Q26866387) (← links)
- Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography (Q28540769) (← links)
- Preclinical Evaluation of 18F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors (Q33793270) (← links)
- Radioiodinated phenylalkyl malonic acid derivatives as pH-sensitive SPECT tracers (Q34311896) (← links)
- Applications of Molecular Imaging (Q35082412) (← links)
- Development of radiotracers for oncology--the interface with pharmacology (Q35195500) (← links)
- Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes (Q35381670) (← links)
- Molecular PET Imaging of Cyclophosphamide Induced Apoptosis with 18F-ML-8 (Q35572605) (← links)
- Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody. (Q35659059) (← links)
- Synthesis of ApoSense compound [18F]2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid ([18F]NST732) by nucleophilic ring opening of an aziridine precursor (Q35977232) (← links)
- A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment (Q36021562) (← links)
- Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis (Q36269742) (← links)
- Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer (Q36920403) (← links)
- The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging (Q37190427) (← links)
- Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters (Q37291272) (← links)
- A HSP60-targeting peptide for cell apoptosis imaging (Q37499284) (← links)
- First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy (Q37668076) (← links)
- Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10. (Q37721557) (← links)
- SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic (Q37746356) (← links)
- Imaging the life and death of tumors in living subjects: Preclinical PET imaging of proliferation and apoptosis (Q37782269) (← links)
- Apoptosis Imaging: Beyond Annexin V (Q37801215) (← links)
- Clinical applications in molecular imaging (Q37815405) (← links)
- Radiotracers for Noninvasive Molecular Imaging of Tumor Cell Death (Q37825911) (← links)
- New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions (Q38040666) (← links)
- Application of microPET imaging approaches in the study of pediatric anesthetic-induced neuronal toxicity (Q38080768) (← links)
- The slow cell death response when screening chemotherapeutic agents (Q38984368) (← links)
- In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors (Q39149494) (← links)
- In Vivo Optical Imaging of Acute Cell Death Using a Near-Infrared Fluorescent Zinc−Dipicolylamine Probe (Q39307808) (← links)
- A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers (Q42142229) (← links)
- Fluorescent light-up probe with aggregation-induced emission characteristics for in vivo imaging of cell apoptosis (Q44364115) (← links)
- Automated radiosynthesis of [(18)F]ML-10, a PET radiotracer dedicated to apoptosis imaging, on a TRACERLab FX-FN module (Q44827159) (← links)
- Microfluidic radiosynthesis and biodistribution of [18 F] 2-(5-fluoro-pentyl)-2-methyl malonic acid (Q44991073) (← links)
- The development of an indirect competitive immunomagnetic-proximity ligation assay for small-molecule detection (Q46125686) (← links)
- In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F]ML-10 in a Stroke Model in the Rat. (Q48158781) (← links)
- MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH (Q48318058) (← links)
- Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10. (Q48473249) (← links)
- Radiolabeled Duramycin: Promising Translational Imaging of Myocardial Apoptosis. (Q49896899) (← links)
- Avenues to molecular imaging of dying cells: Focus on cancer. (Q51734667) (← links)
- Positron emission tomography imaging of cell death with [(18)F]FPDuramycin. (Q53081937) (← links)
- Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers. (Q53091381) (← links)
- 18F-ML-10, a PET Tracer for Apoptosis: First Human Study (Q53230700) (← links)
- Use of LC-MS for the quality control of radiopharmaceuticals: example of [(18)F]ML10. (Q54523609) (← links)
- A novel quenched fluorescent activity-based probe reveals caspase-3 activity in the endoplasmic reticulum during apoptosis† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc03207e. (Q55091784) (← links)
- Radiolabeled apoptosis imaging agents for early detection of response to therapy (Q59100768) (← links)
- Evaluation of apoptosis imaging biomarkers in a genetic model of cell death (Q64258576) (← links)
- [18F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment. (Q64937310) (← links)
- Neuronal Cell Death (Q87906376) (← links)
- [18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer (Q92455021) (← links)